The National Health Service's rollout of data analysis software from controversial technology company Palantir has prompted parliamentary calls for increased oversight and internal warnings to staff about public criticism.

NHS guidance issued this month directs all hospitals to implement Palantir's data platform, a move that has generated significant pushback from members of Parliament who are demanding greater scrutiny of how patient data will be used and protected under the new system.

Separately, senior NHS officials have issued warnings to staff regarding public criticism of the Palantir platform rollout, according to reports. The warnings suggest internal tensions over the implementation of the American company's technology across Britain's public health system.

Palantir, co-founded by billionaire Peter Thiel, has defended its track record amid the controversy. The company's software is designed to analyze large datasets and has been used by government agencies and defense contractors, though its involvement in healthcare data management has raised privacy and transparency concerns among critics.

The timing of the mandatory rollout coincides with broader questions about data management in healthcare systems and the appropriate level of oversight for technology partnerships involving sensitive patient information. Members of Parliament have specifically called for enhanced scrutiny mechanisms to ensure proper governance of the data-sharing arrangements.